BAFNA PHARMACEUTICALS
|
The Current P/S Ratio of BAFNA PHARMACEUTICALS is 1.35.
Share Price | ₹87.3 | Apr 18,2024 |
Market Cap | ₹206.9 Cr | |
Sales-TTM | ₹153.3 Cr | TTM-Standalone Results |
Price/Sales | 1.35x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of BAFNA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹206.9 Cr] as on Apr 18,2024
(/) Sales [ ₹153.3 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.35x ]
Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '1.35 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAFNA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of BAFNA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of BAFNA PHARMACEUTICALS
PS Ratio Performance Analysis for BAFNA PHARMACEUTICALS
- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 2.09x.
- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 1.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 4.56x.
- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.05x.
How does BAFNA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
BAFNA PHARMACEUTICALS | 153.3 | 1.35 | 206.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.67 | 364,015.0 |
CIPLA LTD | 25,350.2 | 4.29 | 108,809.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.65 | 99,408.7 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 4.95 | 94,213.7 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.17 | 98,684.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.66 | 96,037.1 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.23 | 86,219.0 |
LUPIN LTD | 19,480.1 | 3.73 | 72,621.1 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.34 | 65,326.3 |
ABBOTT INDIA LTD | 5,753.4 | 9.62 | 55,366.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAFNA PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.35x |
Max industry PS | 13.17x |
Median industry PS | 4.95x |
Average industry PS | 6.24x |
You may also like the below Video Courses